Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
about
The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD miceElevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development.Slow and steady is the key to beta-cell replication.Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetesStem cell-based strategies for the treatment of type 1 diabetes mellitusTherapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humansEnhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin.Beta cell regeneration after single-round immunological destruction in a mouse model.Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD miceFibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.Centroacinar Cells Are Progenitors That Contribute to Endocrine Pancreas Regeneration.Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 productionTargeting the T-cell membrane type-1 matrix metalloproteinase-CD44 axis in a transferred type 1 diabetes model in NOD mice.Insulin-producing cells derived from stem cells: recent progress and future directions.Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.Cellular therapies for type 1 diabetes.Cytokine related therapies for autoimmune diseaseDiabetes mellitus: an opportunity for therapy with stem cells?Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursorsAre stem cells a cure for diabetes?Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and β cell regeneration in a T1D model.Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders.Myeloid-derived suppressor cells in the inflammatory bowel diseases.The current status of islet transplantation and its perspectives.Recovery from diabetes in mice by beta cell regeneration.Insulin - producing cells derived from stem cells: recent progress and future directions.The effect of gestation and fetal mismatching on the development of autoimmune diabetes in non-obese diabetic mice.
P2860
Q28483660-F82A3A7A-940A-4803-945C-C20598A7ABDBQ33369569-3DEEB814-465E-452A-9DA6-D78A064F2E88Q33647542-0FD3DDB0-B81E-4B16-B41C-202B0DBC6782Q34016151-1A414282-BD18-4922-97E8-B6FE97EA1150Q34417324-3CEA0C9B-58B8-41E6-8DE2-B7B97626AD62Q34612686-F37A2E8E-641F-458B-993A-ED47F3CDBC4CQ34768452-E26535E8-B03A-4D29-859D-F410583564C8Q34770205-4B21807D-BE35-4462-9C83-843A4FF767B5Q34877390-EF9FC4DD-E0AB-4F81-ADF5-690CBCEB1C92Q35616760-F399C9AF-1531-463A-AB61-51289CB4822EQ35893795-CB432235-ECBB-4216-9CC0-3B9AA3B0CF1FQ36104680-2CDA292E-0ED5-44E5-9C34-886262DD56BDQ36446935-92EA61C9-D8A4-4776-A28C-6378CCA01DFCQ36603586-68149830-1728-44B2-B76F-2F0E9CD9062BQ36663038-6E786D93-4538-4412-A6AE-CBF24B0E21C4Q36766176-24FE0F3B-CC0F-4DE2-BC64-07AD0F13D0A7Q37003015-EE6F25F0-7508-4BC2-9861-1F67F7B8F880Q37105570-EF49FEB8-A124-49B5-AB36-CBEC9180BFDEQ37156679-CB193991-A552-4976-BD16-CE08315E14F9Q37360439-A0848545-DAFB-478B-A65B-BD35DC99335FQ37369142-044B829B-811F-4935-8E03-A77B08B0AA6DQ37609481-6C4D14B6-8B98-4130-B2F1-126E2D58C45FQ37704840-9832FF5A-EBFA-4BC6-8F29-8654B7C24FDCQ37727850-08EE0170-3688-409F-AD3C-7D46515EC3D6Q37769927-7EF19F83-DD47-4566-92FE-FCEAED47070FQ38118052-1EED3CF1-25F5-476A-86A4-420FCD7ED8D6Q42279086-8E6C0F5B-38A4-42E0-8FFD-1325BE3FED6AQ42408079-B56A0BEA-8DD7-4E65-BF92-E883C4DCE0C1Q45899851-217205AD-C23C-4076-9A5B-6AAFBC348717Q51345223-741C89E3-DB50-4733-A33A-BF20B09C187F
P2860
Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immunological reversal of auto ...... tic replacement of beta cells.
@ast
Immunological reversal of auto ...... tic replacement of beta cells.
@en
Immunological reversal of auto ...... tic replacement of beta cells.
@nl
type
label
Immunological reversal of auto ...... tic replacement of beta cells.
@ast
Immunological reversal of auto ...... tic replacement of beta cells.
@en
Immunological reversal of auto ...... tic replacement of beta cells.
@nl
prefLabel
Immunological reversal of auto ...... tic replacement of beta cells.
@ast
Immunological reversal of auto ...... tic replacement of beta cells.
@en
Immunological reversal of auto ...... tic replacement of beta cells.
@nl
P2093
P356
P1433
P1476
Immunological reversal of auto ...... etic replacement of beta cells
@en
P2093
Anish Suri
Katherine Frederick
Patrice Bittner
Thomas J Esparza
P304
P356
10.1126/SCIENCE.1123500
P407
P577
2006-03-01T00:00:00Z